Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 12/20 | 0.38 |
| ▸ | PPME1 | Q9Y570 | 1/20 | 0.34 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.34 |
| ▸ | EEF2K | O00418 | 1/20 | 0.34 |
| ▸ | PTGDR | Q13258 | 2/20 | 0.33 |
| ▸ | HTR6 | P50406 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 2/20 | 0.31 |
| ▸ | MMP2 | P08253 | 2/20 | 0.31 |
| ▸ | MMP3 | P08254 | 2/20 | 0.31 |
| ▸ | MMP7 | P09237 | 2/20 | 0.31 |
| ▸ | MMP9 | P14780 | 2/20 | 0.31 |
| ▸ | MMP13 | P45452 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3968730 | 0.93 | PTGDR2 (0.42) | PTGDR2PPME1RAPGEF4EEF2KPTGDR | |
| SCHEMBL3970095 | 0.92 | RAPGEF4 (0.43) | PTGDR2PPME1RAPGEF4PTGDRHTR6 | |
| SCHEMBL3971663 | 0.92 | PTGDR2 (0.45) | PTGDR2PPME1RAPGEF4EEF2KPTGDR | |
| SCHEMBL3967602 | 0.91 | RAPGEF4 (0.34) | PTGDR2PPME1RAPGEF4HTR6 | |
| SCHEMBL3974788 | 0.90 | PTGDR2 (0.46) | PTGDR2PPME1RAPGEF4PTGDR | |
| SCHEMBL3966242 | 0.89 | PTGDR2 (0.38) | PTGDR2PPME1RAPGEF4EEF2KPTGDR | |
| SCHEMBL3969343 | 0.88 | PTGDR2 (0.39) | PTGDR2PPME1RAPGEF4PTGDRHTR6 | |
| SCHEMBL3964356 | 0.86 | PTGDR2 (0.39) | PTGDR2PPME1RAPGEF4PTGDRHTR6 | |
| SCHEMBL3971500 | 0.84 | PTGDR2 (0.39) | PTGDR2RAPGEF4PTGDRHTR6 | |
| SCHEMBL3968885 | 0.83 | PPME1 (0.37) | PTGDR2PPME1RAPGEF4HTR6MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009044147-A1 | INDOLIZINE DERIVATIVES WITH CRTH2 RECEPTOR AFFINITY FOR THE TREATMENT OF INFLAMMATORY DISEASES | ARGENTA DISCOVERY LIMITED (GB) | 2009-04-09 | — | — | WO | disclosed |
| WO-2009044147-A1 | INDOLIZINE DERIVATIVES WITH CRTH2 RECEPTOR AFFINITY FOR THE TREATMENT OF INFLAMMATORY DISEASES | ARGENTA DISCOVERY LIMITED (GB) | 2009-04-09 | — | — | WO | disclosed |